iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
Integrated Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients With Psychiatric Disorders
 
  Reported by Jules Levin
Internati onal Network on Hepatitis Care in Substance Users, 7th International Symposium, 19-21 September 2018, Lisbon, Portugal
 
David Back1, Pamela Belperio2, Mark Bondin3, Francesco Negro4, Andrew H Talal5, Caroline Park3,
Yang Lei3, Brett Pinksy3, Eric Crown3, Federico Mensa3, Fiona Marra1 1University of Liverpool, Liverpool, United Kingdom; 2US Department of Veterans Aff airs, VA Palo Alto Healthcare System, Palo Alto, California, United States; 3AbbVie Inc., North Chicago, Illinois, United States; 4University of Geneva, Geneva, Switzerland; 5Jacobs School of Medicine and Biomedical Sciences, University of Buff alo, Buff alo, New York, United States

0925181

0925182

0925183

0925184

0925185

0925186

0925187

0925188

0925189

09251810

09251811

09251812

09251813

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org